Last updated on August 2014

A clinical trial to evaluate treatments using Ticagrelor 90 mg and Ticagrelor placebo for patients with Type 2 Diabetes Mellitus. THEMIS - effect of Ticagrelor on Health Outcomes in diabetes Mellitus patients Interventional Study


Brief description of study

A clinical trial to evaluate treatments using Ticagrelor 90 mg and Ticagrelor placebo for patients with Type 2 Diabetes Mellitus. THEMIS - effect of Ticagrelor on Health Outcomes in diabetes Mellitus patients Interventional Study

Detailed Study Description

The purpose of the study is to evaluate whether a new antiplatelet therapy, Brilinta® (Ticagrelor) approved by the FDA, for the reduction of major cardiovascular events in patients with certain heart conditions, is effective in preventing the occurrence of heart attack, stroke and/or death due to cardiovascular events in patients who have Type 2 Diabetes Mellitus and known coronary artery disease.

Clinical Study Identifier: TX139070

Find a site near you

Start Over
Sorry. There are no research sites conducting this study in the radius provided. ( View all Sites )

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.